Source:http://linkedlifedata.com/resource/pubmed/id/11034256
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2001-1-17
|
pubmed:abstractText |
The vancomycin pharmacokinetic profile was characterized in six pediatric patients and the potential of nonlinear mixed effects modeling and Bayesian forecasting for vancomycin monitoring was explored using NONMEM V (1.1). Based on steady state serial vancomycin concentrations, the estimates of mean t1/2, Vd, and Cl derived by the Sawchuk and Zaske method (1) were 3.52 hours, 0.57 L/kg, and 0.12 L/h per kg, respectively. NONMEM analysis demonstrated that a weight-adjusted two-compartment model described individual patients' data better than a comparable one-compartment model. The two-compartment estimates of mean t1/2alpha, t1/2beta, Vss, and Cl were 0.80 hour, 5.63 hours, 0.63 L/kg, and 0.11 L/h per kg, respectively. The relatively long mean t1/2alpha suggests that peak vancomycin concentrations measured earlier than 4 hours postdose do not reflect postdistributional serum concentrations. NONMEM population modeling revealed that a weight-adjusted two-compartment model provided a better fit than a comparable one-compartment model. The resulting population parameters and variances were fixed in NONMEM to obtain Bayesian predictions of individual vancomycin serum concentrations. Bayesian estimation with either a single midinterval or trough sample has the potential to provide accurate and precise predictions of vancomycin concentrations. This should be evaluated using a vancomycin population pharmacokinetic model based on a larger sample of pediatric patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0163-4356
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
522-31
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11034256-Anti-Bacterial Agents,
pubmed-meshheading:11034256-Bayes Theorem,
pubmed-meshheading:11034256-Child,
pubmed-meshheading:11034256-Child, Preschool,
pubmed-meshheading:11034256-Cohort Studies,
pubmed-meshheading:11034256-Drug Monitoring,
pubmed-meshheading:11034256-Female,
pubmed-meshheading:11034256-Humans,
pubmed-meshheading:11034256-Male,
pubmed-meshheading:11034256-Vancomycin
|
pubmed:year |
2000
|
pubmed:articleTitle |
Vancomycin pharmacokinetics and Bayesian estimation in pediatric patients.
|
pubmed:affiliation |
Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
|
pubmed:publicationType |
Journal Article
|